These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 11038157)
21. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018 [TBL] [Abstract][Full Text] [Related]
22. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone. Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261 [TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Rifkind AB; Lee C; Chang TK; Waxman DJ Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847 [TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390 [TBL] [Abstract][Full Text] [Related]
25. [O-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes. Rodrigues AD; Surber BW; Yao Y; Wong SL; Roberts EM Drug Metab Dispos; 1997 Sep; 25(9):1097-100. PubMed ID: 9311627 [TBL] [Abstract][Full Text] [Related]
26. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022 [TBL] [Abstract][Full Text] [Related]
27. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310 [TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomes. Ma B; Subramanian R; Schrag ML; Rodrigues AD; Tang C Drug Metab Dispos; 2004 May; 32(5):473-8. PubMed ID: 15100167 [TBL] [Abstract][Full Text] [Related]
29. Phosphonate O-deethylation of [4-(4-bromo-2-cyano-phenylcarbamoyl) benzyl]-phosphonic acid diethyl ester, a lipoprotein lipase-promoting agent, catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes. Morioka Y; Otsu M; Naito S; Imai T Drug Metab Dispos; 2002 Mar; 30(3):301-6. PubMed ID: 11854149 [TBL] [Abstract][Full Text] [Related]
30. Properties and regional expression of a CYP3A-like protein in channel catfish intestine. James MO; Lou Z; Rowland-Faux L; Celander MC Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255 [TBL] [Abstract][Full Text] [Related]
31. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537 [TBL] [Abstract][Full Text] [Related]
32. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Tang C; Shou M; Rodrigues AD Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636 [TBL] [Abstract][Full Text] [Related]
33. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Pharm Sci; 1998 Jul; 87(7):845-53. PubMed ID: 9649353 [TBL] [Abstract][Full Text] [Related]
34. Diazinon is activated by CYP2C19 in human liver. Kappers WA; Edwards RJ; Murray S; Boobis AR Toxicol Appl Pharmacol; 2001 Nov; 177(1):68-76. PubMed ID: 11708902 [TBL] [Abstract][Full Text] [Related]
35. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105 [TBL] [Abstract][Full Text] [Related]
36. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407 [TBL] [Abstract][Full Text] [Related]
37. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam. Tang J; Amin Usmani K; Hodgson E; Rose RL Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087 [TBL] [Abstract][Full Text] [Related]
38. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193 [TBL] [Abstract][Full Text] [Related]
39. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. Li XQ; Björkman A; Andersson TB; Ridderström M; Masimirembwa CM J Pharmacol Exp Ther; 2002 Feb; 300(2):399-407. PubMed ID: 11805197 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of Supermix as an in vitro model of human liver microsomal drug metabolism. Venkatakrishnan K; Von Moltke LL; Greenblatt DJ Biopharm Drug Dispos; 2002 Jul; 23(5):183-90. PubMed ID: 12116049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]